Related Experiment Videos
Ambulatory cervical ripening in term pregnancy
N B Upadhyaya1, K D Childs, R Neiger
1Department of Obstetrics and Gynecology, University of Tennessee Medical Center at Knoxville 37920, USA.
The Journal of Reproductive Medicine
|May 13, 1999
Summary
Outpatient cervical ripening using Dilapan at term is safe and effective. This method significantly reduces hospitalization time and associated costs compared to inpatient care.
Area of Science:
- Obstetrics and Gynecology
- Reproductive Medicine
Background:
- Cervical ripening is crucial for labor induction in term pregnancies with unfavorable cervices.
- Outpatient management strategies aim to improve patient comfort and reduce healthcare costs.
Purpose of the Study:
- To evaluate the safety and efficacy of Dilapan for cervical ripening in an outpatient setting for women at term.
- To compare outpatient versus inpatient cervical ripening with Dilapan.
Main Methods:
- Prospective review of women undergoing cervical ripening with Dilapan at term gestation.
- Patients were randomized to either outpatient or inpatient cervical ripening protocols.
Main Results:
- Induction lengths were comparable between outpatient and inpatient groups (11 ± 7 vs. 14 ± 7 hours).
- Rates of chorioamnionitis, endometritis, and nonreassuring fetal heart rate tracings were similar in both groups.
- Outpatient ripening significantly reduced hospitalization duration (51 ± 27 vs. 70 ± 20 hours; P < .0007).
Conclusions:
- Dilapan is safe and effective for outpatient cervical ripening at term.
- Ambulatory cervical ripening with Dilapan can decrease overall hospitalization time and potentially reduce costs.